Graphene-based phenformin carriers for cancer cell treatment: a comparative study between oxidized and pegylated pristine graphene in human cells and zebrafish†

Graphene is an attractive choice for the development of an effective drug carrier in cancer treatment due to its high adsorption area and pH-responsive drug affinity. In combination with the highly potent metabolic drug phenformin, increased doses could be efficiently delivered to cancer cells. This...

Full description

Bibliographic Details
Main Authors: Alhourani, A. (Author), Eichacker, L.A (Author), Førde, J.-L (Author), Hagland, H.R (Author), Herfindal, L. (Author), Nasrollahzadeh, M. (Author)
Format: Article
Language:English
Published: Royal Society of Chemistry 2022
Subjects:
Online Access:View Fulltext in Publisher